制药工业
政治
业务
制药工业
风险分析(工程)
产业组织
公共经济学
经济
药理学
医学
政治学
工程类
法学
生化工程
出处
期刊:The Lancet
[Elsevier]
日期:2002-11-01
卷期号:360 (9344): 1498-1502
被引量:127
标识
DOI:10.1016/s0140-6736(02)11477-2
摘要
The pharmaceutical industry has produced many drugs that have benefited man. Political frameworks designed to govern the industry must maintain these benefits. However, regulation needs to be sufficiently robust to protect public health from drugs that are unsafe, ineffective, or unnecessary. The extent of industry influence over drug regulation, at the expense of other interested parties, suggests that the current system could be more robust. The many ways in which the pharmaceutical industry can influence governments and regulatory agencies are discussed, and methods by which this influence can be curbed are suggested.
科研通智能强力驱动
Strongly Powered by AbleSci AI